Kawabata, M., & Kaneishi, K. (2013). Continuous subcutaneous infusion of compound oxycodone for the relief of dyspnea in patients with terminally ill cancer: A retrospective study. The American Journal of Hospice & Palliative Care, 30, 305-311.doi: 10.1177/1049909112448924
The objective of this study was to evaluate the efficacy of injectable form of oxycodone on pain and dyspnea in terminally ill patients with cancer.
This single-site study was conducted in an inpatient setting in Japan.
The study was a retrospective, descriptive trial.
A three-point symptom severity verbal rating was used.
Subcutaneous oxycodone administration was effective for reduction of pain and dyspnea in some patients.